SightfileU.S. market data from official filings

PROGYNY INC (PGNY)

Name: PROGYNY INC (PGNY) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001551306 · EDGAR filings · Updated 2026-07-16

PROGYNY INC (PGNY) has reported institutional ownership of 101.9%, with 290 institutional managers holding positions valued at $1.36B per the latest 13F reporting period.

Institutional ownership

101.9%

Institutional managers

290

Reported 13F value

$1.36B

Insider activity

67 trans.

$980.4K net buying

Latest updates

2026-07-16 — Insider transaction reported (Form 4)
2026-07-14 — Notice of proposed sale filed (Form 144)
2026-06-23 — Insider transaction reported (Form 4)
2026-06-08 — SCHEDULE 13G/A filed
2026-06-05 — Insider transaction reported (Form 4)
2026-06-05 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, PROGYNY INC has 290 institutional holders and institutional ownership of 101.9%.

Insider activity

Insiders reported 67 transactions (1 buys, 13 sells) across 13 reporting insiders, with a net reported value of $980.4K.

Related companies

Procept Biorobotics Corp (PRCT) · BICARA THERAPEUTICS INC (BCAX) · KALVISTA PHARMACEUTICALS INC (KALV) · IMMUNITYBIO INC (IBRX) · QUIDELORTHO CORP (QDEL) · HEALTHCARE SVCS GROUP INC (HCSG)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-16.